Outcomes | > 5 years from disease-onset to bDMARD start, adjusted for JIA categoryc and gender | > 5 years from disease-onset to bDMARD start, adjusted for JIA categoryc, gender, disease duration, and disease activity | ||
---|---|---|---|---|
Beta/OR (95% CI) | p-value | Beta/OR (95% CI) | p-value | |
Remission on medicationa | 0.61 (0.25; 1.49) | 0.278 | 2.47 (0.55; 11.12)d | 0.240 |
Remission off medicationa | 0.28 (0.12; 1.66) | 0.003 | 0.24 (0.06; 0.92)d | 0.038 |
HAQ total scoreb | 0.48 (0.27; 0.68) | < 0.001 | 0.05 (− 0.18; 0,28) | 0.687 |
SF 36 physical componentb | − 10.63 (− 16.00; − 5.27) | < 0.001 | − 0.01 (− 8.76; 6.85) | 0.997 |
PFb | − 29.29 (− 41.79; − 16.79) | < 0.001 | − 2.88 (.17.70; 11.94) | 0.700 |
RPb | − 25.57 (− 40.82; − 10.32) | 0.001 | 0.53 (− 19.38; 20.44) | 0.958 |
BPb | − 14.82 (− 25.62; − 4.03) | 0.007 | 2.63 (− 10.59; 15.84) | 0.694 |
GHb | − 7.59 (− 16.86; 1.69) | 0.108 | − 0.26 (− 12.68; 12.17) | 0.967 |
SF36 mental componentb | − 6.16 (− 14.50; 2.18) | 0.147 | − 0.41 (− 11.83; 11.00) | 0.944 |
VTb | − 10.73 (− 19.05; − 2.41) | 0.012 | − 3.81 (− 14.98; 7.36) | 0.500 |
SFb | − 15.49 (− 26.15; − 4.84) | 0.005 | − 8.00 (− 22.39; 6.40) | 0.273 |
REb | − 14.63 (− 28.63; − 0.64) | 0.041 | − 3.61 (− 16.91; 24.14) | 0.727 |
MHb | − 5.95 (− 14.27; 2.46) | 0.165 | − 1.60 (− 12.76; 9.56) | 0.776 |
Joint surgeriesa | 26.6 (3.62; 195.34) | 0.001 | 7.33 (0.82; 65.62) | 0.075 |